Camarillo, CA, United States of America

Gamze Ozlem Camdere

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gamze Ozlem Camdere. Retrieved from https://idiyas.com/inventor/gamze-ozlem-camdere

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gamze Ozlem Camdere: Innovator in Cancer Treatment

Introduction

Gamze Ozlem Camdere is a prominent inventor based in Camarillo, California. She has made significant contributions to the field of cancer treatment through her innovative research and development of antibodies.

Latest Patents

Gamze holds a patent for "Antibodies against MICA and/or MICB and uses thereof." This patent provides antibodies that specifically bind to human MICA/B and outlines methods for their use. Notably, the disclosure includes methods for treating cancer in a subject by administering an anti-MICA/B antibody.

Career Highlights

Gamze is currently employed at Bristol-Myers Squibb Company, where she continues to advance her research in oncology. Her work focuses on developing therapeutic solutions that can improve patient outcomes in cancer treatment.

Collaborations

Gamze collaborates with esteemed colleagues, including Michelle Renee Kuhne and Alan J Korman, to further enhance the impact of her research in the medical field.

Conclusion

Gamze Ozlem Camdere's innovative work in developing antibodies for cancer treatment exemplifies her commitment to advancing medical science. Her contributions are paving the way for new therapeutic approaches that could benefit many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…